News & Events
Exciting News
April 12, 2025
Happy Birthday William!
In honor of William's Birthday, we are happy to donate $5,000 to Christopher's Haven. This amazing Boston based charity helps children and families with a temporary comfortable place to stay when managing through cancer treatments.
William would be so proud to support such a great place.
To learn more visit: www.christophershaven.org
September, 2024
We are proud to support Dr. Patrick Grohar, who is dedicated to finding the cure for
Sarcoma Cancer.
Dr. Grohar's lab at C.S. Mott Children's Hospital is primarily focused on the therapeutic targeting of the EWS-FLI1 transcription factor; the oncogenic driver of Ewing sarcoma. Through a bench-to-bedside approach, he and his team are turning lab discoveries into real treatments that can impact patients today. He has several ongoing projects in the key areas of discovery, mechanistic pharmacology, translational studies and clinical trials - all aimed at finding ways to treat "undruggable cancers like Ewing sarcoma. to learn more visit: www.groharlab.org
July, 2024
The Kettle Restaurant in Wilton, NH has teamed up with von Trapp Brewing, Stowe, VT to create an amazing house beer called Echo Love Lager. Some of the proceeds from the sales of this beer will be donated to our foundation. What an incredibly kind and generous way to help us find the cure for Sarcoma Cancer. Visit: www.copperkettletogo.com
January, 2024
Scientists at Cold Spring Harbor Laboratory have discovered a
new drug target for Ewing sarcoma, a rare kind of cancer usually diagnosed in
children and young adults.
In support of this amazing work, a $10,000 donation was made to
Dr. Christopher Vakoc and the dedicated team at Vakoc Lab.
To learn more visit: Stopping a rare childhood cancer in its tracks | Cold Spring Harbor Laboratory (cshl.edu)
July 15, 2023
July is Sarcoma Cancer Awareness Month
A $10,000 Donation was made to the incredible Stegmaier Laboratory at
Dana-Farber Cancer Institute.
We will continue to find and support Drs and research teams
that are in the forefront of Sarcoma cancer breakthroughs.
Thank you Dr. Stegmaier and the entire Stegmaier Lab team
for your tireless efforts to help find new discoveries for
Sarcoma Cancer treatment options.
To learn more about the Stegmaier Laboratory visit: Stegmaier Lab (harvard.edu)
April 12, 2022
In Honor of William’s Birthday,
a $5,000 Donation to The Integrative Therapies Program at
Mass General Cancer Center
This support program offers free wellness services, like acupuncture, yoga and music therapy. This program was so helpful to Bill during his cancer treatments. Thank you to amazing team members like Hugo Lopez and Irene Martyniuk for their kindness and talent. So grateful for all you do every day to help others.
January 12, 2022
The William J. Riley Foundation is proud to announce a $10,000 donation has been made to support Dr. Timothy Chan, and his exciting new research.
A team lead by Dr. Chan at Cleveland Clinic are working together with the focused goal of achieving groundbreaking treatment options to offer hope for pediatric and young adult patients facing aggressive cancers like Ewing's Sarcoma.
Dr. Chan has discovered that neoantigens can be targeted by immunotherapies that reactivate patient immune cells. Dr. Chan is working on developing immunotherapy options to save lives and move away from toxic therapies and toward personalized treatments that use the body's own cells to achieve remission.
Targeted research efforts like this will help move forward the treatment options and potential cure for Sarcoma cancer.
Thank you, Dr. Chan for your dedication to finding the answer.
April 12, 2021
William J. Riley Foundation is proud to announce a $20,000 donation made to Cold Spring Harbor Laboratory in support of Dr. Christopher Vakoc MD, PhD. for his sarcoma cancer research.
Dr Vakoc and his team are working on discoveries that will be highly impactful in the hunt for drug targets in Ewing sarcoma and rhabdomyosarcoma.
Cancer cells achieve their pathogenicity by changing which genes are on and off. To maintain these changes in gene expression, cancer cells rely on proteins that interact with DNA or modify chromatin. Dr. Vakoc and his team investigate how such factors sustain the aberrant capabilities of cancer cells, thereby identifying new therapeutic targets. Cold Spring Harbor Laboratory is a National Cancer Institute designated center for Cancer Research
August, 2020
The William J. Riley Foundation, Inc. is pleased to announce that a $15,000 Donation was
made to Cold Spring Harbor Laboratory, NY.
This gift will specifically benefit the Sarcoma Cancer Research under the direction of
Dr. Chris Vakoc, M.D.,Ph.D.
Dr. Vakoc is utilizing CRISPR to identify new targets for sarcoma cancer treatments. These discoveries are leading them to investigate the possibility that Ewing sarcoma cancer cells
can be tricked into becoming ‘normal’ cells. Dr. Vakoc says: “Our ongoing work is investigating how these targets feed cancer growth and we seek to find chemicals that selectively block their function”
The William J. Riley Foundation is dedicated to supporting Sarcoma Cancer Research and we are proud to help fund Dr. Vakoc with such important work.
November 23, 2019
William J. Riley Foundation, Inc. a charitable organization, announces $10,000 donation to Cleveland Clinic supporting Dr. Jacob Scott’s Ewing Sarcoma Cancer Research program.
Jacob Scott, MD, DPhil, and his team are evolving drug resistance in Ewing's Sarcoma cell lines. By examining the changes that occur in the cell's genomes, they hope to understand why drugs stop working for patients and can help guide future treatment options.
To learn more about Dr. Scott and his work at Cleveland Clinic, visit: https://www.lerner.ccf.org/Thor/Scott/lab/people/
August 16, 2019
The William J. Riley Foundation is pleased to announce that a $10,000 Donation will be used to support the Sarcoma Cancer research efforts of Dr. Edwin Choy from Mass General Cancer Center, Boston, MA. Dr. Choy and his team conduct research primarily via clinical trials, where promising sarcoma agents are tested in the clinic. Their work is currently centering on a drug called cabozantinib, that might be the next new drug for treating sarcoma. He is currently working with the manufacturer in trying to design a national clinical trial for this drug to try to get FDA approval. In addition, Dr. Choy is interested in immunotherapy options for patients. In particular, trying to treat NY-ESO and other sarcoma antigens which might be targets that our own immune system could use.
For more information see Dr. Choy's research abstract and publications on this web site: http://www.dfhcc.harvard.edu/insider/member-detail/member/edwin-choy-md-phd/
December, 2018
Willam J. Riley Foundation has recently made a $10,000 donation to Cold Spring Harbor Laboratory Sarcoma Research Program. Brilliant doctors and scientists are working hard to find a cure. We are honored to support this amazing research laboratory